# Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

> **NCT04575519** · PHASE2 · UNKNOWN · sponsor: **Fundació Institut Germans Trias i Pujol** · enrollment: 354 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary
- Tuberculosis, MDR
- Tuberculosis Infection

## Interventions

- **DRUG:** Control group
- **DRUG:** ASA group
- **DRUG:** IBU group
- **DRUG:** SoC TB

## Key facts

- **NCT ID:** NCT04575519
- **Lead sponsor:** Fundació Institut Germans Trias i Pujol
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-04
- **Primary completion:** 2024-10
- **Final completion:** 2025-06
- **Target enrollment:** 354 (ESTIMATED)
- **Last updated:** 2024-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04575519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04575519, "Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04575519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*